Treating tobacco use and dependence in kidney transplant recipients: development and implementation of a program.
Tobacco use adversely affects transplant outcomes such as graft survival, patient survival, and other conditions that alter transplant patient longevity. Especially concerning is tobacco's relationship to cardiovascular disease, the number 1 cause of death in kidney transplant recipients. Many authors conclude that tobacco interventions ought to be provided to patients and sometimes lament that there are no tobacco dependence interventions designed for kidney transplant recipients. European Best Practice Guidelines for Renal Transplantation also support tobacco dependence interventions. The purpose of this article is to describe one institution's experience in implementing the clinical practice guideline for treating tobacco use and dependence within a kidney and pancreas transplant program.
Ehlers
Shawna L
SL
Mayo Clinic, Rochester, Minn, USA.
Rodrigue
James R
JR
Patton
Pamela R
PR
Lloyd-Turner
Joni
J
Kaplan
Bruce
B
Howard
Richard J
RJ